Blood Diagnostics, Inc. Announces First Quarter Growth

COLUMBIA, SC--(Marketwire - April 25, 2008) - Blood Diagnostics, Inc. (BDI), a national leader in the distribution of biopharmaceutical products, announced that sales for the first quarter of 2008 represented a twenty-seven percent (27%) increase in comparison to Q1 2007. This pace is ahead of the company's average rate of growth for the preceding three fiscal calendar years. BDI's revenues have grown at an average rate of twenty-three percent (23%) per year from 2004 - 2007.